MedPath

TCM BIOTECH INTERNATIONAL CORP.

TCM BIOTECH INTERNATIONAL CORP. logo
๐Ÿ‡น๐Ÿ‡ผTaiwan
Ownership
Public
Established
1998-01-01
Employees
101
Market Cap
-
Website
http://www.tcmbio.com

Clinical Trials

6

Active:0
Completed:2

Trial Phases

4 Phases

Phase 1:1
Phase 2:1
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
2 (40.0%)
Phase 1
1 (20.0%)
Phase 2
1 (20.0%)
Phase 3
1 (20.0%)

Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women

Not Applicable
Recruiting
Conditions
Recurrent Urinary Tract Infections in Women
Interventions
Other: Placebo
First Posted Date
2025-09-22
Last Posted Date
2025-09-22
Lead Sponsor
TCM Biotech International Corp.
Target Recruit Count
348
Registration Number
NCT07184827
Locations
๐Ÿ‡จ๐Ÿ‡ณ

Chang Gung Memorial Hospital, Kaohsiung Branch, Kaohsiung City, Taiwan

๐Ÿ‡จ๐Ÿ‡ณ

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan

๐Ÿ‡จ๐Ÿ‡ณ

Taipei Tzu Chi Hospital, New Taipei City, Taiwan

and more 10 locations

Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects

Not Applicable
Recruiting
Conditions
NAFLD
First Posted Date
2023-07-05
Last Posted Date
2025-04-10
Lead Sponsor
TCM Biotech International Corp.
Target Recruit Count
108
Registration Number
NCT05930093
Locations
๐Ÿ‡จ๐Ÿ‡ณ

National Taiwan University Hospital, Taipei City, Not required for this country, Taiwan

Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence

Completed
Conditions
Hepatocellular Carcinoma
First Posted Date
2023-04-21
Last Posted Date
2024-04-10
Lead Sponsor
TCM Biotech International Corp.
Target Recruit Count
207
Registration Number
NCT05823584
Locations
๐Ÿ‡จ๐Ÿ‡ณ

National Taiwan University Hospital, Taipei, Taiwan

A Study of PTX-9908 Injection for Non-resectable HCC with TACE

Phase 1
Recruiting
Conditions
Carcinoma, Hepatocellular
Interventions
Drug: PTX-9908 Injection
Drug: Placebo
First Posted Date
2019-01-23
Last Posted Date
2024-11-21
Lead Sponsor
TCM Biotech International Corp.
Target Recruit Count
50
Registration Number
NCT03812874
Locations
๐Ÿ‡จ๐Ÿ‡ณ

National Taiwan University Hospital, New Taipei City, Taiwan

The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)

Phase 3
Withdrawn
Conditions
Chronic Hepatitis C
Interventions
First Posted Date
2013-07-01
Last Posted Date
2017-04-28
Lead Sponsor
TCM Biotech International Corp.
Registration Number
NCT01890200
Locations
๐Ÿ‡จ๐Ÿ‡ณ

Peking University People's Hospit, Beijing, Beijing, China

๐Ÿ‡จ๐Ÿ‡ณ

Chang Gung Memorial Hospital, Taoyuan, Taiwan

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.